title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
"The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug",20220708T121902,https://www.benzinga.com/general/biotech/22/07/27998206/the-daily-biotech-pulse-pfizer-inks-pact-with-africa-for-covid-19-pills-emergent-bio-ridgeback-to,PRVB,0.126985,Neutral,0.002849
"Accolade Shares Jump Around 29%, Here's 75 Biggest Movers From Friday",20220705T083503,https://www.benzinga.com/news/22/07/27948361/accolade-shares-jump-around-29-heres-75-biggest-movers-from-friday,PRVB,0.061758,Neutral,0.013549
Why Shares of MacroGenics Climbed Thursday,20230316T161729,https://www.fool.com/investing/2023/03/16/why-shares-of-macrogenics-climbed-thursday/,PRVB,0.1331,Neutral,-0.011236
MacroGenics  ( MGNX )  Q4 2022 Earnings Call Transcript,20230316T030035,https://www.fool.com/earnings/call-transcripts/2023/03/15/macrogenics-mgnx-q4-2022-earnings-call-transcript/,PRVB,0.025272,Neutral,0.096817
Provention  ( PRVB )  Skyrockets 260% on Buyout Offer From Sanofi,20230314T163200,https://www.zacks.com/stock/news/2065615/provention-prvb-skyrockets-260-on-buyout-offer-from-sanofi,PRVB,0.597963,Somewhat-Bullish,0.271196
"Illumina, Seagen And Other Big Stocks Moving Higher On Monday - Agenus  ( NASDAQ:AGEN ) , First Majestic Silver  ( NYSE:AG ) ",20230313T145550,https://www.benzinga.com/news/23/03/31322709/illumina-seagen-and-other-big-stocks-moving-higher-on-monday,PRVB,0.162802,Bullish,0.371688
Why Shares of MacroGenics Jumped Thursday,20230309T205900,https://www.fool.com/investing/2023/03/09/why-shares-of-macrogenics-jumped-thursday/,PRVB,0.131643,Somewhat-Bullish,0.202812
DRI Healthcare Trust Announces Acquisition of a Royalty Interest in the Worldwide Sales of TZIELDâ„¢  ( teplizumab-mzwv )  and Updates Long-Term Cash Receipts Outlook,20230308T223000,https://www.newswire.ca/news-releases/dri-healthcare-trust-announces-acquisition-of-a-royalty-interest-in-the-worldwide-sales-of-tzield-tm-teplizumab-mzwv-and-updates-long-term-cash-receipts-outlook-870382808.html,PRVB,0.030408,Neutral,0.060126
Why Shares of MacroGenics Were Dropping Tuesday,20221122T165558,https://www.fool.com/investing/2022/11/22/why-shares-of-macrogenics-were-dropping-tuesday/,PRVB,0.131643,Neutral,0.149093
Provention  ( PRVB )  Gets FDA Nod for Drug That Delays T1D Onset,20221118T151500,https://www.zacks.com/stock/news/2019947/provention-prvb-gets-fda-nod-for-drug-that-delays-t1d-onset,PRVB,0.568651,Bullish,0.424427
Why Provention Bio  ( PRVB )  Shares Are Trading Higher Premarket Today? - Provention Bio  ( NASDAQ:PRVB ) ,20221118T113942,https://www.benzinga.com/general/biotech/22/11/29780945/first-drug-that-can-delay-onset-of-type-1-diabetes-gets-fda-approval-after-multiple-regulatory-hu,PRVB,0.507107,Neutral,0.120552
"Gap, Palo Alto Networks And Some Other Big Stocks Moving Higher In Today's Pre-Market Session - Applied Materials  ( NASDAQ:AMAT ) , Foot Locker  ( NYSE:FL ) ",20221118T111100,https://www.benzinga.com/news/22/11/29781391/gap-palo-alto-networks-and-some-other-big-stocks-moving-higher-in-todays-pre-market-session,PRVB,0.247838,Neutral,-0.069558
U.S. FDA greenlights Provention Bio's diabetes drug,20221117T233200,https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-greenlights-provention-bios-diabetes-drug-2022-11-17/,PRVB,0.235823,Neutral,0.058954
MacroGenics Earns $60 Million Milestone with U.S. FDA Approval of Teplizumab,20221117T231000,https://www.globenewswire.com/news-release/2022/11/17/2558767/0/en/MacroGenics-Earns-60-Million-Milestone-with-U-S-FDA-Approval-of-Teplizumab.html,PRVB,0.04882,Neutral,0.11993
MacroGenics Earns $60 Million Milestone with U.S. FDA Approval of Teplizumab - Macrogenics  ( NASDAQ:MGNX ) ,20221117T231000,https://www.benzinga.com/pressreleases/22/11/g29777756/macrogenics-earns-60-million-milestone-with-u-s-fda-approval-of-teplizumab,PRVB,0.047559,Neutral,0.117834
Provention Bio Reports Third Quarter 2022 Financial Results and Provides Business Update,20221103T110000,https://www.prnewswire.com/news-releases/provention-bio-reports-third-quarter-2022-financial-results-and-provides-business-update-301667012.html,PRVB,0.12546,Neutral,0.047891
"Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know - iShares Biotechnology ETF  ( NASDAQ:IBB ) , BondBloxx ETF Trust BondBloxx BB-Rated USD High Yield Corporate Bond ETF  ( ARCA:XBB ) ",20221101T200154,https://www.benzinga.com/general/biotech/22/11/29508633/provention-bios-second-try-apelliss-eye-disorder-drug-review-3-adcom-verdicts-and-more-novembers-,PRVB,0.062761,Neutral,0.0
MacroGenics  ( MGNX )  Q2 2022 Earnings Call Transcript,20220809T043033,https://www.fool.com/earnings/call-transcripts/2022/08/09/macrogenics-mgnx-q2-2022-earnings-call-transcript/,PRVB,0.008813,Neutral,0.106296
Provention Bio Reports Second Quarter 2022 Financial Results and Provides Business Update,20220804T110852,https://www.prnewswire.com/news-releases/provention-bio-reports-second-quarter-2022-financial-results-and-provides-business-update-301599729.html,PRVB,0.135062,Neutral,0.041663
Provention Bio Reports First Quarter 2022 Financial Results and Provides Business Update,20220505T110000,https://www.prnewswire.com/news-releases/provention-bio-reports-first-quarter-2022-financial-results-and-provides-business-update-301540118.html,PRVB,0.126152,Neutral,0.027797
Why MacroGenics Stock Is Tanking Today,20220504T164715,https://www.fool.com/investing/2022/05/04/why-macrogenics-stock-is-tanking-today/,PRVB,0.112744,Neutral,-0.000879
"Regional banks pace decliners, as biotech deals lift Seagen and Provention Bio",20230313T143200,https://www.marketwatch.com/story/regional-banks-pace-decliners-as-biotech-deals-lift-seagen-and-provention-bio-78a5d161,PRVB,0.485711,Bullish,0.609613
